Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Rosuvastatin | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Rosuvastatin | hsa00564 | Glycerophospholipid metabolism | 2.28E-02 | 3 | Q9Y259, P23743, Q3LIE5 | CHKB, DGKA, ADPRM | More | | Rosuvastatin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.21E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Rosuvastatin | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Rosuvastatin | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Rosuvastatin | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Rosuvastatin | hsa03013 | RNA transport | 2.35E-05 | 10 | O14980, P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF4A2, EIF4B, TACC3 | More | | Rosuvastatin | hsa03040 | Spliceosome | 1.08E-02 | 7 | O43143, P08579, Q07955, P84103, Q13243, P11142, O75643 | DHX15, SNRPB2, SFRS1, SFRS3, SFRS5, HSPA8, ASCC3L1 | More | | Rosuvastatin | hsa04012 | ErbB signaling pathway | 4.75E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Rosuvastatin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Rosuvastatin | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Rosuvastatin | hsa04064 | NF-kappa B signaling pathway | 2.15E-02 | 7 | P14778, P19174, Q04759, P06239, P09341, P19875, Q06643 | IL1R1, PLCG1, PRKCQ, LCK, CXCL1, CXCL2, LTB | More | | Rosuvastatin | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Rosuvastatin | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Rosuvastatin | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Rosuvastatin | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Rosuvastatin | hsa04650 | Natural killer cell mediated cytotoxicity | 2.48E-03 | 8 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3 | More | | Rosuvastatin | hsa04658 | Th1 and Th2 cell differentiation | 1.62E-05 | 9 | Q04759, P07766, P20963, P19174, P06239, P42224, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, STAT1, TBX21, IL2RB, RUNX3 | More | | Rosuvastatin | hsa04659 | Th17 cell differentiation | 2.08E-04 | 10 | Q04759, P19174, P06239, P42224, P14784, P14778, Q9UL17, P08238, P07766, P20963 | PRKCQ, PLCG1, LCK, STAT1, IL2RB, IL1R1, TBX21, HSP90AB1, CD3E, CD247 | More | | Rosuvastatin | hsa04660 | T cell receptor signaling pathway | 3.37E-03 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | | Rosuvastatin | hsa04664 | Fc epsilon RI signaling pathway | 4.75E-02 | 3 | P07948, P19174, P09917 | LYN, PLCG1, ALOX5 | More | | Rosuvastatin | hsa04727 | GABAergic synapse | 3.40E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Rosuvastatin | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Rosuvastatin | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Rosuvastatin | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Rosuvastatin | hsa05034 | Alcoholism | 8.66E-03 | 6 | Q13547, P63218, P50151, Q93077, P62807, O60814 | HDAC1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC12 | More | | Rosuvastatin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.78E-03 | 5 | P09341, P19875, P19174, P25024, P25025 | CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Rosuvastatin | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Rosuvastatin | hsa05145 | Toxoplasmosis | 3.59E-02 | 5 | P42224, P09917, Q13751, P11142, Q13651 | STAT1, ALOX5, LAMB3, HSPA8, IL10RA | More | | Rosuvastatin | hsa05146 | Amoebiasis | 2.21E-04 | 8 | P09341, P19875, P14778, P27930, P42338, P11215, P05089, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, PIK3CB, ITGAM, ARG1, ACTN1 | More | | Rosuvastatin | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.79E-02 | 6 | P42224, P63218, P50151, P19174, P07948, P01106 | STAT1, GNG5, GNG10, PLCG1, LYN, MYC | More | | Rosuvastatin | hsa05169 | Epstein-Barr virus infection | 1.43E-02 | 8 | P01106, Q13547, P07948, P30101, Q13761, O75293, P42224, P07766 | MYC, HDAC1, LYN, PDIA3, RUNX3, GADD45B, STAT1, CD3E | More | | Rosuvastatin | hsa05200 | Pathways in cancer | 5.69E-03 | 14 | Q13751, P08238, P42224, P19174, P01106, P43246, P20585, Q13547, P49767, P63218, P50151, P78417, O75293, P14784 | LAMB3, HSP90AB1, STAT1, PLCG1, MYC, MSH2, MSH3, HDAC1, VEGFC, GNG5, GNG10, GSTO1, GADD45B, IL2RB | More | | Rosuvastatin | hsa05203 | Viral carcinogenesis | 4.33E-02 | 6 | P07948, P29083, Q13547, P12814, P62807, O60814 | LYN, GTF2E1, HDAC1, ACTN1, HIST1H2BC, H2BC12 | More | | Rosuvastatin | hsa05206 | MicroRNAs in cancer | 3.79E-02 | 6 | P30304, P09493, P01106, Q9Y4H2, Q13547, P19174 | CDC25A, TPM1, MYC, IRS2, HDAC1, PLCG1 | More | | Rosuvastatin | hsa05231 | Choline metabolism in cancer | 1.08E-02 | 4 | O15245, Q9Y259, P19174, P23743 | SLC22A1, CHKB, PLCG1, DGKA | More | | Rosuvastatin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | |